Citigroup Inc. Increases Stock Holdings in Perrigo Company plc $PRGO

Citigroup Inc. raised its position in shares of Perrigo Company plc (NYSE:PRGOFree Report) by 110.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 89,197 shares of the company’s stock after purchasing an additional 46,848 shares during the quarter. Citigroup Inc. owned 0.06% of Perrigo worth $1,986,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Norges Bank bought a new stake in Perrigo during the second quarter valued at approximately $36,755,000. Perpetual Ltd grew its position in shares of Perrigo by 64.2% during the 3rd quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock valued at $70,148,000 after acquiring an additional 1,231,400 shares during the period. Ion Asset Management Ltd. grew its position in shares of Perrigo by 34.7% during the 2nd quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after acquiring an additional 983,727 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Perrigo by 126.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after purchasing an additional 647,982 shares in the last quarter. Finally, State Street Corp raised its holdings in Perrigo by 9.5% in the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after purchasing an additional 637,678 shares during the period. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. JPMorgan Chase & Co. cut their price target on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Jefferies Financial Group reiterated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a research note on Friday, February 13th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Perrigo in a research report on Monday, December 22nd. Finally, Argus raised shares of Perrigo to a “hold” rating in a research note on Wednesday, January 14th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $19.33.

Check Out Our Latest Stock Analysis on PRGO

Perrigo Stock Performance

NYSE:PRGO opened at $10.75 on Monday. The company has a current ratio of 2.76, a quick ratio of 1.63 and a debt-to-equity ratio of 1.23. Perrigo Company plc has a 12-month low of $10.65 and a 12-month high of $29.08. The stock has a 50-day moving average price of $14.19 and a 200 day moving average price of $16.99. The stock has a market capitalization of $1.48 billion, a P/E ratio of -1.05, a P/E/G ratio of 1.29 and a beta of 0.41.

Perrigo (NYSE:PRGOGet Free Report) last issued its earnings results on Thursday, February 26th. The company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.80 by ($0.03). Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same period last year, the business posted $0.93 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 10.8%. The ex-dividend date of this dividend is Monday, March 2nd. Perrigo’s payout ratio is -11.28%.

About Perrigo

(Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.